45 CFR § 180 compliance
F · 55
This hospital published little of what § 180 requires.
●Machine-readable file published
○Gross / standard charges
○Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
15,465
Insurances with rates
2
CPT / HCPCS codes
13,657
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J9228 | IPILIMUMAB 5 MG/ML INJECTION (SO) | $119,455 | $47,782 | — | — | 8 |
| C1882 | HC IMPLANT AICD OTHER | $110,943 | $44,377 | — | — | 3 |
| J9269 | TAGRAXOFUSP-ERZS 1,000 MCG/ML INTRAVENOUS SOLUTION | $108,194 | $43,278 | — | — | 4 |
| J2507 | PEGLOTICASE 8 MG/ML INTRAVENOUS SOLUTION | $100,211 | $40,084 | — | — | 8 |
| J3357 | USTEKINUMAB 90 MG/ML SUBCUTANEOUS SYRINGE | $97,450 | $38,980 | — | — | 3 |
| J9281 | MITOMYCIN 40 MG X 2 INTRA-PYELOCALYCEAL KIT | $82,845 | $33,138 | — | — | 5 |
| J1303 | RAVULIZUMAB-CWVZ 100 MG/ML INTRAVENOUS SOLUTION | $82,185 | $32,874 | — | — | 8 |
| 33262 | HC REPLACE GENERATOR ONLY (ICD) SINGLE | $80,022 | $32,009 | — | — | 5 |
| 33263 | HC REPLACE GENERATOR ONLY (ICD) DUAL | $80,022 | $32,009 | — | — | 4 |
| 33231 | HC INSERT GENERATOR ONLY (ICD) TO EXISTING MULTIPLE LEADS | $80,022 | $32,009 | — | — | 4 |
| 33264 | HC REPLACE GENERATOR ONLY (ICD) MULTIPLE | $80,022 | $32,009 | — | — | 4 |
| 33230 | HC INSERT GENERATOR ONLY (ICD) TO EXISTING DUAL LEADS | $80,022 | $32,009 | — | — | 4 |
| C2616 | YTTRIUM-90 BRACHYTX SRC NON-STRANDED | $79,875 | $31,950 | — | — | 4 |
| 33249 | HC INS RPL ICD SYSTEM DUAL | $78,241 | $31,297 | — | — | 5 |
| 33270 | HC INSERT/REPLACE (SICD) SUBCUTANEOUS ICD SYSTEM | $71,036 | $28,414 | — | — | 4 |
| A9543 | Y-90 ZEVALIN | $70,810 | $28,324 | — | — | 4 |
| J2350 | OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION | $69,000 | $27,600 | — | — | 5 |
| C1722 | HC IMPLANT AICD SINGLE | $68,301 | $27,321 | — | — | 3 |
| 33276 | HC INSERT PHRENIC NERVE STIM SYS W/ IMAGING GDNCE | $67,856 | $27,142 | — | — | 4 |
| 33287 | HC RMVL & REPLCMNT PHRENIC NERVE STIM PULSE GEN | $67,856 | $27,142 | — | — | 4 |
| J7311 | FLUOCINOLONE 0.59 MG INTRAVITREAL IMPLANT | $66,588 | $26,635 | — | — | 5 |
| J9266 | PEGASPARGASE 750 UNIT/ML INJECTION SOLUTION | $65,105 | $26,042 | — | — | 4 |
| C9606 | HC COR REVASC ACUTE MI DRUG-ELUTING STENT/PTA/ATHERECT INITIAL VES | $62,470 | $24,988 | — | — | 3 |
| J3245 | TILDRAKIZUMAB-ASMN 100 MG/ML SUBCUTANEOUS SYRINGE | $60,331 | $24,132 | — | — | 4 |
| J3241 | TEPROTUMUMAB-TRBW 500 MG INTRAVENOUS SOLUTION | $55,721 | $22,288 | — | — | 5 |
| J9298 | NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION | $50,864 | $20,345 | — | — | 4 |
| J9307 | PRALATREXATE 40 MG/2 ML (20 MG/ML) INTRAVENOUS SOLUTION | $47,513 | $19,005 | — | — | 5 |
| 33208 | HC INSERT/REPLACE (PACEMAKER) DUAL RT ATRIAL & RT VENTRICULAR LEAD SYSTEM | $43,548 | $17,419 | — | — | 4 |
| C9607 | HC COR REVASC CHRONIC OCC DRUG-ELUTING STENT/PTA/ATHERECT INITIAL VES | $43,532 | $17,413 | — | — | 4 |
| 92943 | HC COR REVASC CHRONIC OCC BARE METAL STENT/PTA/ATHERECT INITIAL VES | $43,034 | $17,214 | — | — | 4 |
| 33229 | HC REPLACE GENERATOR ONLY (PACEMAKER) MULTIPLE | $40,350 | $16,140 | — | — | 5 |
| 33228 | HC REPLACE GENERATOR ONLY (PACEMAKER) DUAL | $40,350 | $16,140 | — | — | 5 |
| 33221 | HC INSERT GENERATOR ONLY (PACEMAKER) TO EXISTING MULTIPLE LEADS | $40,350 | $16,140 | — | — | 4 |
| C9604 | HC COR REVASC GRAFT DRUG ELUTING STENT/PTA/ATHERECT INITIAL VESSEL FA | $39,679 | $15,871 | — | — | 5 |
| J9042 | BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLUTION | $39,557 | $15,823 | — | — | 5 |
| C2621 | HC IMPLANT PACER OTHER | $38,552 | $15,421 | — | — | 3 |
| J9043 | CABAZITAXEL 10 MG/ML (FIRST DILUTION) INTRAVENOUS SOLUTION | $37,846 | $15,138 | — | — | 4 |
| J9022 | ATEZOLIZUMAB 1,200 MG/20 ML (60 MG/ML) INTRAVENOUS SOLUTION | $37,121 | $14,848 | — | — | 4 |
| 33227 | HC REPLACE GENERATOR ONLY (PACEMAKER) SINGLE | $36,789 | $14,716 | — | — | 4 |
| J2329 | UBLITUXIMAB-XIIY 25 MG/ML INTRAVENOUS SOLUTION | $36,654 | $14,662 | — | — | 4 |
| J9119 | CEMIPLIMAB-RWLC 50 MG/ML INTRAVENOUS SOLUTION | $34,993 | $13,997 | — | — | 5 |
| A9604 | SAMARIUM-153 LEXIDRONAM | $34,493 | $13,797 | — | — | 4 |
| J2327 | RISANKIZUMAB-RZAA 60 MG/ML INTRAVENOUS SOLUTION | $34,321 | $13,728 | — | — | 4 |
| J9203 | GEMTUZUMAB OZOGAMICIN 4.5 MG (1 MG/ML INITIAL CONCENTRATION) IV SOLN | $34,126 | $13,650 | — | — | 5 |
| J9144 | DARATUMUMAB 1,800 MG-HYALURONIDASE-FIHJ 30,000 UNIT/15 ML SUBCUT SOLN | $33,926 | $13,570 | — | — | 4 |
| C1764 | HC IMPLANT CARDIAC EVENT REC | $31,818 | $12,727 | — | — | 3 |
| 33212 | HC INSERT GENERATOR ONLY (PACEMAKER) TO EXISTING SINGLE LEAD | $31,528 | $12,611 | — | — | 4 |
| J1932 | LANREOTIDE 120 MG/0.5 ML SUBCUTANEOUS SYRINGE | $31,124 | $12,450 | — | — | 4 |
| J3380 | VEDOLIZUMAB 300 MG INTRAVENOUS SOLUTION | $30,333 | $12,133 | — | — | 4 |
| C9047 | CAPLACIZUMAB-YHDP 11 MG INJECTION KIT | $28,847 | $11,539 | — | — | 4 |
Showing top 50 of 15,465 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.